{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:53:07Z","timestamp":1793296387880,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA49449"],"award-info":[{"award-number":["R01 CA49449"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA67262"],"award-info":[{"award-number":["R01 CA67262"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01 CA176726"],"award-info":[{"award-number":["U01 CA176726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UM1 CA186107"],"award-info":[{"award-number":["UM1 CA186107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES027706"],"award-info":[{"award-number":["ES027706"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.envres.2021.112222","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T14:25:59Z","timestamp":1634567159000},"page":"112222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: A nested case control analysis in the Nurses\u2019 Health Study cohorts"],"prefix":"10.1016","volume":"207","author":[{"given":"Paul","family":"Lochhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin N.","family":"Ananthakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envres.2021.112222_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for ibd","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.envres.2021.112222_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/ibd.21455","article-title":"Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis","volume":"17","author":"Ananthakrishnan","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.envres.2021.112222_bib3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","article-title":"Origin, methods, and evolution of the three nurses' health studies","volume":"106","author":"Bao","year":"2016","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.envres.2021.112222_bib4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the u.S. Population: data from the national health and nutrition examination survey (nhanes) 2003-2004 and comparisons with nhanes 1999-2000","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2021.112222_bib5","doi-asserted-by":"crossref","first-page":"105048","DOI":"10.1016\/j.envint.2019.105048","article-title":"Legacy and alternative per- and polyfluoroalkyl substances in the u.S. General population: paired serum-urine data from the 2013-2014 national health and nutrition examination survey","volume":"131","author":"Calafat","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.envres.2021.112222_bib6","series-title":"Per- and Polyfluorinated Substances (Pfas) Tables, Nhanes 2011-2018","year":"2021"},{"key":"10.1016\/j.envres.2021.112222_bib7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3945\/jn.111.157222","article-title":"Alternative dietary indices both strongly predict risk of chronic disease","volume":"142","author":"Chiuve","year":"2012","journal-title":"J. Nutr."},{"key":"10.1016\/j.envres.2021.112222_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.71.3.388","article-title":"The role of ppars in inflammation and immunity","volume":"71","author":"Clark","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.envres.2021.112222_bib9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/labinvest.3700185","article-title":"Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (ppar-alpha) in the development of inflammatory bowel disease in mice","volume":"84","author":"Cuzzocrea","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.envres.2021.112222_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of ppars in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.envres.2021.112222_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fphar.2020.00730","article-title":"Peroxisome proliferator-activated receptors: experimental targeting for the treatment of inflammatory bowel diseases","volume":"11","author":"Decara","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.envres.2021.112222_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/1547691X.2014.996682","article-title":"Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: role of pparalpha and t- and b-cell targeting","volume":"13","author":"DeWitt","year":"2016","journal-title":"J. Immunot."},{"key":"10.1016\/j.envres.2021.112222_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/tox.20642","article-title":"Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male c57bl\/6 mice","volume":"27","author":"Dong","year":"2012","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.envres.2021.112222_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","author":"Fenton","year":"2020","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.envres.2021.112222_bib15","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1289\/ehp.0800379","article-title":"The c8 health project: design, methods, and participants","volume":"117","author":"Frisbee","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2021.112222_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijheh.2008.04.007","article-title":"Perfluorinated compounds--exposure assessment for the general population in western countries","volume":"212","author":"Fromme","year":"2009","journal-title":"Int. J. Hyg Environ. Health"},{"key":"10.1016\/j.envres.2021.112222_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/jes.2014.54","article-title":"Distribution of perfluoroalkyl compounds in rats: indication for using hair as bioindicator of exposure","volume":"25","author":"Gao","year":"2015","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.envres.2021.112222_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.envres.2021.112222_bib19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/87.17.1297","article-title":"Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women","volume":"87","author":"Hankinson","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.envres.2021.112222_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.chroma.2008.10.113","article-title":"A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring","volume":"1216","author":"Haug","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.envres.2021.112222_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2105\/AJPH.2016.303348","article-title":"Diet assessment methods in the nurses' health studies and contribution to evidence-based nutritional policies and guidelines","volume":"106","author":"Hu","year":"2016","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.envres.2021.112222_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of ibd: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.envres.2021.112222_bib23","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/ajg.2010.252","article-title":"The inflammatory bowel diseases and ambient air pollution: a novel association","volume":"105","author":"Kaplan","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.envres.2021.112222_bib24","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the u.S. Population: 1999-2008","volume":"45","author":"Kato","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envres.2021.112222_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.chemosphere.2012.11.013","article-title":"Effect of temperature and duration of storage on the stability of polyfluoroalkyl chemicals in human serum","volume":"91","author":"Kato","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.envres.2021.112222_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/j.gastro.2012.07.096","article-title":"Hormone therapy increases risk of ulcerative colitis but not crohn's disease","volume":"143","author":"Khalili","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.envres.2021.112222_bib27","first-page":"1378","article-title":"Endogenous levels of circulating androgens and risk of crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts","volume":"21","author":"Khalili","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.envres.2021.112222_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00415-016-8340-8","article-title":"Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis","volume":"264","author":"Kosmidou","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.envres.2021.112222_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"Half-lives of pfos, pfhxs and pfoa after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.envres.2021.112222_bib30","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1021\/es2011622","article-title":"Polyfluorinated compounds: past, present, and future","volume":"45","author":"Lindstrom","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envres.2021.112222_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/j.gastro.2020.05.011","article-title":"Dietary inflammatory potential and risk of crohn's disease and ulcerative colitis","volume":"159","author":"Lo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.envres.2021.112222_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.01.016","article-title":"Association between circulating levels of c-reactive protein and interleukin-6 and risk of inflammatory bowel disease","volume":"14","author":"Lochhead","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol. : the official clinical practice journal of the American Gastroenterological Association"},{"key":"10.1016\/j.envres.2021.112222_bib33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0016-5085(98)70421-4","article-title":"Crohn's disease in olmsted county, Minnesota, 1940-1993: incidence, prevalence, and survival","volume":"114","author":"Loftus","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.envres.2021.112222_bib34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.46.3.336","article-title":"Ulcerative colitis in olmsted county, Minnesota, 1940-1993: incidence, prevalence, and survival","volume":"46","author":"Loftus","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.envres.2021.112222_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0272-0590(92)90047-L","article-title":"Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests","volume":"18","author":"Luster","year":"1992","journal-title":"Fund. Appl. Toxicol. : official journal of the Society of Toxicology"},{"key":"10.1016\/j.envres.2021.112222_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-019-01901-0","article-title":"Dietary intake of fish, n-3 polyunsaturated fatty acids, and risk of inflammatory bowel disease: a systematic review and meta-analysis of observational studies","volume":"59","author":"Mozaffari","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.envres.2021.112222_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-069X-11-10","article-title":"Social disparities in exposures to bisphenol a and polyfluoroalkyl chemicals: a cross-sectional study within nhanes 2003-2006","volume":"11","author":"Nelson","year":"2012","journal-title":"Environ. Health"},{"key":"10.1016\/j.envres.2021.112222_bib38","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2021.112222_bib39","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10620-016-4249-4","article-title":"Exposure to ambient air pollution and the risk of inflammatory bowel disease: a european nested case-control study","volume":"61","author":"Opstelten","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.envres.2021.112222_bib40","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a116211","article-title":"Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals","volume":"135","author":"Rimm","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envres.2021.112222_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/aje\/kwm348","article-title":"Determination of blood pressure percentiles in normal-weight children: some methodological issues","volume":"167","author":"Rosner","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envres.2021.112222_bib42","article-title":"Risk to human health related to the presence of perfluoroalkyl substances in food","volume":"18","author":"Schrenk","year":"2020","journal-title":"EFSA J"},{"key":"10.1016\/j.envres.2021.112222_bib43","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/es102769t","article-title":"Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington works facility in West Virginia","volume":"45","author":"Shin","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envres.2021.112222_bib44","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1289\/ehp.1206449","article-title":"Ulcerative colitis and perfluorooctanoic acid (pfoa) in a highly exposed population of community residents and workers in the mid-Ohio valley","volume":"121","author":"Steenland","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2021.112222_bib45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/oemed-2014-102364","article-title":"A cohort incidence study of workers exposed to perfluorooctanoic acid (pfoa)","volume":"72","author":"Steenland","year":"2015","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.envres.2021.112222_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.envres.2018.05.007","article-title":"Pfoa and ulcerative colitis","volume":"165","author":"Steenland","year":"2018","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2021.112222_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/pr.2015.213","article-title":"Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National health and nutrition examination survey","volume":"79","author":"Stein","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.envres.2021.112222_bib48","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1021\/es7032058","article-title":"Perfluorinated compounds in house dust from Ohio and North Carolina, USA","volume":"42","author":"Strynar","year":"2008","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envres.2021.112222_bib49","doi-asserted-by":"crossref","DOI":"10.1289\/EHP2619","article-title":"Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: a prospective investigation among u.S. Women","volume":"126","author":"Sun","year":"2018","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2021.112222_bib50","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1038\/s41598-017-04091-z","article-title":"Perfluorooctane sulfonate affects intestinal immunity against bacterial infection","volume":"7","author":"Suo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2021.112222_bib51","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1111\/j.1572-0241.2008.02158.x","article-title":"An update on the epidemiology of inflammatory bowel disease in asia","volume":"103","author":"Thia","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.envres.2021.112222_bib52","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","article-title":"Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women","volume":"66","author":"Tworoger","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.envres.2021.112222_bib53","doi-asserted-by":"crossref","first-page":"108923","DOI":"10.1016\/j.envres.2019.108923","article-title":"Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water","volume":"181","author":"Xu","year":"2020","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2021.112222_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/1547691X.2010.537287","article-title":"Type 1 and type 2 cytokines imbalance in adult male c57bl\/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (pfos)","volume":"8","author":"Zheng","year":"2011","journal-title":"J. Immunot."},{"key":"10.1016\/j.envres.2021.112222_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10098-011-0375-z","article-title":"Progress and perspective of perfluorinated compound risk assessment and management in various countries and institutes","volume":"14","author":"Zushi","year":"2012","journal-title":"Clean Technol. Environ. Policy"}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935121015231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935121015231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T02:44:24Z","timestamp":1762137864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935121015231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":55,"alternative-id":["S0013935121015231"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2021.112222","relation":{},"ISSN":["0013-9351"],"issn-type":[{"value":"0013-9351","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: A nested case control analysis in the Nurses\u2019 Health Study cohorts","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2021.112222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112222"}}